Health Encyclopedia

Meningitis - H. influenzae

Definition

Haemophilus influenzae meningitis is a bacterial infection of the membranes covering the brain and spinal cord (meninges).

Alternative Names

H. influenzae meningitis; H. flu meningitis

Causes, incidence, and risk factors

H. influenzae meningitis is caused by Haemophilus influenzae bacteria. This bacteria should not be confused with the disease influenza, an upper respiratory infection caused by the influenza virus.

Before the Hib vaccine became available, H. influenzae was the leading cause of bacterial meningitis in children under 5 years of age. Since the introduction of the vaccine in the U.S., H. influenzae now occurs in less than 2 in 100,000 children. It still causes 5% - 10% of bacterial meningitis cases in adults.

H. influenzae meningitis may come after an upper respiratory infection. The infection usually spreads from the respiratory tract to the bloodstream, and then to the meninges. At the meninges, the bacteria produce infection and inflammation, causing serious illness and sometimes death.

Risk factors include:

Ear infection (otitis media)
Family member with an H. influenzae infection
Native American race
Placement in day care
Sinus infection (sinusitis)
Sore throat (pharyngitis)
Upper respiratory infection

Symptoms

Fever (in young infants the temperature may actually be below normal)
Irritability, poor feeding in infants
Nausea and vomiting
Pain in back when neck is bent forward and chin is brought toward chest (older children)
Sensitivity to light (photophobia)
Severe headache (older children)
Stiff neck or pain in neck
Unusual body positions

Signs and tests

Signs include:

Bulging of the fontanelles in an infant
Lying with the back arched, head, back, and chin up (opisthotonos)
Mental status changes (such as irritability, reduced consciousness, coma)
Poor blood flow (circulation)
Seizures

For any patient with meningitis, it is important to perform a lumbar puncture ("spinal tap"), in which spinal fluid (known as cerebrospinal fluid, or CSF) is collected for testing.

Other tests include:

Antibodies in blood (serology)
Blood culture
Spinal fluid culture
White blood cell count

Treatment

Treatment must be started as soon as meningitis is suspected. H. influenzae meningitis should be treated with antibiotics given through a vein (IV).

Steroid medication may also be used, mostly in children. Steroids are given to reduce hearing loss, which is a common complication of meningitis in children.

Expectations (prognosis)

The likely outcome is good with early treatment. However, 3 - 5% of patients do not survive.

Complications

Abnormal speech and language development
Behavioral problems
Hearing loss
Hydrocephalus
Learning disorders
Mental retardation
Seizures

Calling your health care provider

Contact your health care provider or go to an emergency room if you experience symptoms of H. influenzae or if you notice these symptoms in your child. Meningitis can quickly become life-threatening.

Prevention

To protect infants and young children:

Hib immunizations for infants and children are recommended by the American Academy of Pediatrics, the National Institutes of Health, and many other health agencies.
Several types of Hib vaccine are available for children ages 2 months and older.

To prevent infection after being exposed to H. influenzae meningitis:

All family contacts of people with this type of meningitis who have not been vaccinated should begin drug therapy to prevent infection as soon as possible.
Ask your health care provider about this treatment during the first visit.

References

Swartz MN. Meningitis: bacterial, viral, and other. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007: chap 437.

Review Date:9/28/2008
Reviewed By:David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; and Jatin M. Vyas, PhD, MD, Instructor in Medicine, Harvard Medical School, Assistant in Medicine, Division of Infectious Disease, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

ADAM Quality A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The Agency for Health Care Administration (Agency) and this website do not claim the information on, or referred to by, this site is error free. This site may include links to websites of other government agencies or private groups. Our Agency and this website do not control such sites and are not responsible for their content. Reference to or links to any other group, product, service, or information does not mean our Agency or this website approves of that group, product, service, or information.

Additionally, while health information provided through this website may be a valuable resource for the public, it is not designed to offer medical advice. Talk with your doctor about medical care questions you may have.